Drug Verapamil shown to slow T1D progression in newly diagnosed
A new study has shown drug Verapamil, regularly used to treat blood pressure, can slow type 1 diabetes progression in newly diagnosed children and teens.
As researchers work to cure type 1 diabetes (T1D), the ultimate goal is to prevent the destruction of beta cells that produce insulin. A new JDRF-funded clinical trial reveals a potential path to keeping beta cells alive for longer.
The clinical trial looked at whether adding verapamil, a drug normally used to treat blood pressure, could preserve the function of beta cell function in children and teens newly diagnosed with T1D.
The study found that newly diagnosed individuals on verapamil were making more insulin one year after diagnosis than those on placebo, with the average C-peptide, which is used to measure beta cell function, being 30% higher in the verapamil group compared to the control group.
If you would like to read more about this exciting clinical trial head to JDRF International for a full write up.
How your gift can help make history: Research that’s changing the future of type 1 diabetes
Type 1 diabetes (T1D) is a condition which currently affects over 130,000 Australians, with a further 8 people diagnosed each day. JDRF has a vision of turning these numbers to zero and creating a world where T1D does not exist. How? By supporting the most promising research focused on finding cures and improving lives until […]
JDRF advocate Shanna McGrath receives Mark Butler Local Legend Award
Each year during National Volunteers Week, the Minister for Health, Hon Mark Butler, announces the winners of the Mark Butler MP Volunteer Awards. These awards recognise the local volunteers in his electorate, Hindmarsh, who are dedicated to improving the needs of the community organisations they represent. JDRF advocate, Shanna McGrath, was diagnosed with T1D when […]
Our 2023 Volunteer of the Year winners
It’s National Volunteer Week and this year’s theme is ‘change makers’. At JDRF, we know that no change for type 1 diabetes (T1D) has happened without the dedication of volunteers across the community. We are an organisation who was founded by volunteers and is still powered by them, including (but not limited to!) our amazing […]
Dr Ki Wook Kim awarded JDRF Career Development Award to improve type 1 diabetes risk prediction
Dr Ki Wook Kim, a prominent Australian researcher and emerging leader in type 1 diabetes (T1D) research based at the UNSW Sydney, has been awarded a JDRF Career Development Award (CDA) with US $1M funding committed over the next five years. Dr Kim is one of only 13 Australians to ever receive the JDRF Career […]